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Abstract
OBJECTIVE—To assess knowledge, attitudes, and practices of obstetrician–gynecologists (ob-
gyns) regarding vaccination of pregnant women during the 2009 H1N1 pandemic.
METHODS—From February to July 2010, a self-administered mail survey was conducted among 
a random sample of American College of Obstetricians and Gynecologists (the College) members 
involved in obstetric care. To assess predictors of routinely offering influenza vaccination, 
adjusted prevalence ratios and 95% confidence intervals (CIs) were calculated from survey data.
RESULTS—Among 3,096 survey recipients, 1,310 (42.3%) responded to the survey, of whom 
873 were eligible for participation. The majority of ob-gyns reported routinely offering both 
seasonal and 2009 H1N1 influenza vaccination to their pregnant patients (77.6% and 85.6%, 
respectively) during the 2009–2010 season; 21.1% and 13.3% referred patients to other specialists. 
Reported reasons for not offering vaccination included inadequate reimbursement, storage 
limitations, or belief that vaccine should be administered by another provider. Seasonal and 2009 
H1N1 influenza vaccination during the first trimester was not recommended by 10.6% and 9.6% 
of ob-gyns, respectively. Predictors of routinely offering 2009 H1N1 influenza vaccine included: 
considering primary care and preventive medicine a very important part of practice (adjusted 
prevalence ratio 1.2, CI 1.01–1.4); observing serious conditions attributed to influenza-like illness 
(adjusted prevalence ratio 1.1, CI 1.02–1.1); personally receiving 2009 H1N1 influenza 
vaccination (adjusted prevalence ratio 1.2, CI 1.1–1.4); and practicing in multispecialty group 
(adjusted prevalence ratio 1.1, CI 1.1–1.2). Physicians in solo practice were less likely to routinely 
offer influenza vaccine (adjusted prevalence ratio 0.8, CI 0.7–0.9).
CONCLUSION—Although most ob-gyns routinely offered influenza vaccination to pregnant 
patients, vaccination coverage rates may be improved by addressing logistic and financial 
challenges of vaccine providers.
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Pregnant women are at increased risk for influenza-related morbidity, adverse pregnancy 
outcomes, and mortality, especially during pandemics.1–9 During the 2009 H1N1 pandemic, 
pregnant women accounted for approximately 5% of influenza-associated deaths in the 
United States, although they represent only approximately 1% of the population.6
Influenza vaccination during pregnancy is the most effective way to prevent influenza virus 
infection among pregnant women10 and their infants younger than 6 months of age.11,12 
Although administration of inactivated influenza vaccine is recommended to all women who 
are pregnant during the influenza season, regardless of pregnancy trimester,10,13 the 
vaccination coverage among pregnant women has been historically low, rarely exceeding 
15% during nonpandemic years.10,14 The reasons for low uptake of vaccination during 
pregnancy include factors related to the lack of vaccine acceptance by pregnant women, as 
well as barriers among health care providers, including absence of financial incentives, 
liability concerns, logistic obstacles, and lack of confidence about vaccine safety and 
benefits.15–22
Obstetrician– gynecologists (ob-gyns), who are often the only providers of health care 
during pregnancy, play a critical role in preventing influenza in their patients through 
vaccination and implementing recommended diagnostic, treatment, and infection control 
practices. Understanding the barriers that prevent ob-gyns from administering influenza 
vaccination is critical for attaining high vaccination rates among pregnant women. In 
February 2010, just after the peak of the 2009 H1N1 pandemic, we conducted a survey 
among the national sample of U.S. ob-gyns to assess their knowledge, attitudes, and 
practices regarding influenza vaccination during pregnancy, and the barriers and facilitators 
to influenza vaccination.
MATERIALS AND METHODS
A self-administered survey was mailed to a U.S. nationally representative random sample of 
3,116 ob-gyns using the American College of Obstetricians and Gynecologists database. 
Only ob-gyns currently involved in obstetric patient care were eligible to participate; those 
not eligible were instructed to return the uncompleted survey. The sampling frame consisted 
of 33,685 practicing ob-gyns who were College fellows or junior fellows. The survey was 
accompanied by a cover letter and prepaid envelope; no incentives were offered to the 
participants. The initial mailing was sent in February 2010. Second, third, and fourth 
mailings were sent to all nonrespondents at 4- to 5-week intervals. The survey included 
questions about the basic demographic information of respondents and their patients, 
respondents’ experiences with serious conditions attributed to influenza-like illness among 
pregnant women in their practice (during both 2008–2009 influenza season and 2009 H1N1 
pandemic), and respondents’ attitudes and practices regarding influenza vaccination of 
pregnant women (with both seasonal and 2009 H1N1 influenza vaccines) during the 2009 
H1N1 pandemic. Five weeks after the fourth mailing, a short questionnaire was sent to all 
nonrespondents to gather data for an assessment of possible nonresponse bias in which their 
responses were compared with those of study participants.
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Analyses were performed using SAS 9.1 and SPSS 16.0. We calculated frequency 
distributions of responses to each question in the survey, excluding nonresponses from the 
denominators. For multilevel responses, we performed multiple tests using SAS 
“MULTTEST” procedure. Two-sided Cochran-Armitage linear trend tests23 and a 
significance level of P<.05 were used to compare differences in responses for the 2008–
2009 and 2009–2010 influenza seasons, and for seasonal and 2009 H1N1 influenza 
vaccines.
To assess the association between selected characteristics and routinely offering 2009 H1N1 
influenza vaccine by ob-gyns, we conducted log-binomial regression analyses, which 
included variables on the basis of their univariable association with the outcome (routinely 
offering 2009 H1N1 influenza vaccine); adjusted prevalence ratios and 95% confidence 
intervals (CIs) were calculated using SAS “GENMOD” log-binomial regression 
capability.24 Using this approach, log-probability link function is used, and the adjusted 
estimates of coefficients of the examined factors represent logarithms of the adjusted 
prevalence ratios. Because of multicollinearity between three variables (practice type, 
considers primary care or preventive medicine an important part of practice, and received 
2009 H1N1 influenza vaccination themselves), three separate models were constructed. The 
project was reviewed for human subject concerns by the Centers for Disease Control and 
Prevention and the College and was determined to qualify for exempt status.
RESULTS
Of the 3,116 surveys mailed, 20 were returned as undeliverable. Among the ob-gyns who 
received the survey, 1,784 did not respond, 2 refused participation, and 1,310 returned the 
survey for a response rate of 42.3% (1,310 of 3,096). Of 1,310 providers who returned the 
surveys, 873 (66.6%) were providing obstetric care during the 2009–2010 influenza season 
and therefore were eligible to participate in the study, and their responses were included in 
the analyses.
The respondents had a mean age of 49 years, approximately half were female, and their 
average duration of clinical practice was 17 years (Table 1). The majority of respondents 
were practicing in a group obstetrics-gynecology practice (48.1%), followed by solo practice 
(16.4%), multispecialty group practice (12.4%), university full-time faculty and practice 
(11.2%), and other (11.9%, including Health Maintenance Organization, military, and 
combination of these). Almost all respondents considered primary care or preventive 
medicine an important part of their clinical practice. Among the patient population of the 
respondents, a third were eligible for Medicaid, and race or ethnicity distribution was as 
follows: 54.9% were non-Hispanic white, 15.2% were non-Hispanic African American, 
17.8% were Hispanic, 5.3% were Asian or Pacific Islander, and 1.3% were Native 
American.
In response to the question “During last year’s (2008–2009) and this year’s (2009–2010) 
influenza seasons, have you seen the following conditions in your practice that you attribute 
to influenza-like illness,” the proportion of ob-gyns who reported observing at least one of 
the serious conditions (maternal death, pneumonia requiring intensive care, spontaneous 
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abortion or stillbirth, or preterm birth) doubled from 14.6% during the 2008–2009 influenza 
season to 31.1% during the 2009–2010 influenza season (P<.001). During the 2009 H1N1 
pandemic, survey results indicated a threefold increase in the proportion of ob-gyns who 
reported observing maternal deaths, twofold increase in the proportion observing 
pneumonias requiring intensive care, twofold increase in the proportion observing 
spontaneous abortions or stillbirths, and 50% increase in the proportion observing preterm 
births attributed to influenza-like illness (based on their clinical judgment) compared with 
the previous influenza season (Fig. 1).
During the 2009 H1N1 pandemic (2009–2010 influenza season), the majority of ob-gyns 
reported routinely offering influenza vaccination, both seasonal (77.6%) and 2009 H1N1 
(85.6%), to their pregnant patients; most of the remaining providers reported referring their 
patients to other providers for seasonal (21.1%) and 2009 H1N1 (13.3%) vaccines. Only 
approximately 1% of providers neither offered nor referred their pregnant patients for 
influenza vaccination (Table 2). Pregnant patients with underlying chronic conditions were 
offered vaccine at approximately the same rate as low-risk patients; however, providers were 
slightly less likely to offer both seasonal and 2009 H1N1 influenza vaccines for pregnant 
patients with prepregnancy obesity. The following reasons for not offering vaccinations 
were reported by ob-gyns (percentages for seasonal and 2009 H1N1 influenza vaccines, 
respectively): not adequately reimbursed by insurance (34.9% and 31.7%); no adequate 
storage and handling facilities for vaccines (28.0% and 35.8%); vaccine offered by closely 
affiliated clinic (21.7% and 28.5%); managed care contract does not cover the cost of 
vaccines and vaccine administration (20.1% and 17.1%); and belief that vaccines should be 
administered by another provider, such as an internist or family practitioner (15.3% and 
14.6%). Although the percentage of respondents offering influenza vaccination to pregnant 
women was significantly greater for the 2009 H1N1 influenza vaccine as compared with 
seasonal influenza vaccine, recommendations to use influenza vaccine did not differ by 
vaccine type (seasonal or 2009 H1N1). The majority of respondents recommended influenza 
vaccination at any trimester of pregnancy; however, 10–11% recommended influenza 
vaccination only during the second or third trimester of pregnancy (Table 2). Almost all 
respondents reported that their medical practice either required (approximately 34%) or 
strongly encouraged (62–63%) them to receive an influenza vaccination, and almost all (90–
92%) reported having actually received an influenza vaccination during the previous 
influenza season. Unvaccinated respondents provided the following reasons for not getting 
vaccination: unable to find the vaccine; had allergic reaction to influenza vaccines in the 
past; had influenza before vaccine became available; had no time for vaccination; or stated 
that there was no particular reason. These reasons did not differ by vaccine type.
The most commonly cited sources of guidance regarding influenza vaccinations were the 
College and the Centers for Disease Control and Prevention, cited by 60.8% and 54.1% 
respondents, respectively. Other sources of information included local public health 
departments (18.8%), their own practice (11.9%), scientific literature (5.6%), and media 
(3.9%). Fewer than half (46.6%) of respondents stated that they report suspected adverse 
events after administering influenza vaccine; when asked how adverse events should be 
reported, only 13.1% specified the Vaccine Adverse Event Reporting System or Centers for 
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Disease Control and Prevention (which cosponsors Vaccine Adverse Event Reporting 
System).
Among ob-gyns, predictors of routinely offering the 2009 H1N1 vaccination to pregnant 
women included considering primary care or preventive medicine to be a very important 
part of practice (adjusted prevalence ratio 1.2, CI 1.01–1.4), observing serious conditions 
attributed to influenza-like illness in their practice (adjusted prevalence ratio 1.1, CI 1.02–
1.1), and personally receiving 2009 H1N1 influenza vaccination (adjusted prevalence ratio 
1.2, CI 1.1–1.4; Table 3). In addition, practice type was an independent predictor of 
routinely offering 2009 H1N1 vaccine; compared with providers in group obstetrics-
gynecology practice, providers in solo practice were less likely (adjusted prevalence ratio 
0.8, CI 0.7–0.9) and providers in multispecialty group were more likely (adjusted prevalence 
ratio 1.1, CI 1.1–1.2) to offer 2009 H1N1 influenza vaccine. The 202 nonrespondents who 
returned the short follow-up letter survey did not differ from the full survey respondents in 
years of clinical practice, proportion of patients eligible for Medicaid, or the likelihood of 
routinely offering influenza vaccinations to pregnant women.
DISCUSSION
During the 2009 H1N1 pandemic, ob-gyns were critical to the public health response for 
preventing severe complications of influenza virus among pregnant women. Although most 
ob-gyns participating in this survey routinely offered influenza vaccinations to their patients, 
a considerable proportion of respondents did not offer vaccination or did not recommend 
vaccination in the first trimester of pregnancy, which represents a missed opportunity for 
preventing influenza virus infection and its serious consequences.
We found that ob-gyns routinely offered seasonal and 2009 H1N1 influenza vaccines to 
their pregnant patients during the 2009–2010 influenza season at a higher rate than reported 
from surveys of U.S. obgyns in previous influenza seasons,15,18 –22,25 which could be 
attributable to increased awareness regarding influenza in pregnancy during the pandemic 
season and increased demand for vaccination among pregnant women. Our study showed 
that providers who observed at least one of the serious conditions attributed to influenza-like 
illness were more likely to offer 2009 H1N1 influenza vaccine to their pregnant patients. In 
addition, during the 2009 H1N1 pandemic, ob-gyns were frequently reminded about the 
importance of influenza vaccination during pregnancy by media, publications in scientific 
journals, and letters from professional associations and governmental agencies.26 Provision 
of 2009 H1N1 vaccine at no cost to vaccination providers could also have motivated ob-
gyns to become vaccinators and may explain why more providers offered 2009 H1N1 than 
seasonal influenza vaccine. Recently published influenza vaccination coverage rates among 
pregnant women support our finding of the significant increase in providing vaccination 
among ob-gyns; in the 2009–2010 influenza season, approximately 50% of pregnant women 
received influenza vaccination,27 which is the highest coverage level ever reported in the 
United States, getting closer to the Healthy People 2020 goal of 80% coverage.28
Barriers to recommending and administering influenza vaccination among ob-gyns in our 
sample included inadequate reimbursement and absence of storage and handling facilities 
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for vaccines (which require refrigeration and protection from light). These financial and 
logistic concerns are not unique for influenza vaccines and have been consistently reported 
in previous surveys of obstetric providers.15–19,21,22 However, concerns about the safety of 
influenza vaccines reported in previous studies19,22 were uncommon in our survey, which 
occurred toward the end of the 2009–2010 influenza season, when speculations about safety 
of influenza vaccination had been mitigated. Solo practice providers, which represented 
16.4% of ob-gyns in our sample, were less likely to offer influenza vaccination, but more 
likely (compared with other practice types) to consider primary care or preventive medicine 
a very important part of their clinical practice (analysis not shown). This suggests that 
barriers to vaccination among solo practice providers are more difficult to overcome than 
among those who practice in partnerships and groups.
One of the limitations of the study is the relatively low response rate, which is, however, 
slightly higher than reported in previous random surveys of general College members 
(averaged 40%).29 It is also possible that characteristics of respondents are different from 
that of nonrespondents, although nonresponse bias analysis did not reveal statistically 
significant differences for comparison variables. Importantly, the characteristics of 
respondents in our sample are similar to those of U.S. ob-gyns in general,30 and the 
characteristics of their patients are similar to those of U.S. women giving birth.31 As with 
most surveys, our study has inherent limitations of self-reported data, which can be subject 
to response bias. Because we collected our data immediately after the 2009 H1N1 pandemic 
season, our findings may not be generalizable to a nonpandemic influenza season, when 
fewer patients experience serious consequences of influenza, demand for vaccination is 
decreased, vaccine is no longer free, and pressure from professional associations is lower. 
Preliminary data from the 2010–2011 influenza season suggest that observed improvement 
of influenza vaccination coverage rates among pregnant women could be sustainable.32
Improving vaccination coverage rates during pregnancy is one of the main public health 
goals during both influenza pandemics and nonpandemic influenza seasons, because of its 
role in decreasing influenza-related morbidity and mortality among pregnant women and 
their young infants. For many women, ob-gyns are the only providers of health care.33 By 
not offering influenza vaccination to such women, providers miss a unique opportunity for 
prevention. Although demand for influenza vaccination from pregnant women plays an 
important role, research shows that when women are offered vaccination, most tend to 
accept it.15,20,27,34,35 Given that influenza vaccination reduces health care, societal, and 
individual costs, as well as productivity losses and absenteeism associated with influenza,10 
policy improvements to allow more reliable reimbursement for vaccine providers, especially 
those in solo practice, might be beneficial for the society. A number of strategies (eg, patient 
reminder systems) have been successful in improving the role of obstetric providers as 
vaccinators and need to be used more widely,36–38 which can become even more feasible 
when electronic health records are widely implemented. Obgyns played a crucial role in 
increasing the national influenza vaccination coverage rates among pregnant women during 
the 2009 H1N1 pandemic and need to sustain their role as vaccinators during coming 
influenza seasons.
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Proportion of U.S. obstetrician– gynecologists who reported observing at least one of the 
serious conditions (maternal death, pneumonia requiring intensive care, spontaneous 
abortion or stillbirth, or preterm birth) in their practices that they attributed to influenza-like 
illness among pregnant women during the 2008–2009 influenza season (black bars) and 
2009–2010 influenza seasons (gray bars).
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Table 1





  Female 51.1
  Male 48.9
Average age (y) 49 (30–85)
Average years in practice 17 (0.5–52)
Type of practice
  Group obstetrics-gynecology 48.1
  Solo 16.4
  Multispecialty group 12.4
  University full-time faculty and practice 11.2
  Other 11.9
Consider primary care, preventive medicine an important part of practice
  Very important 45.8
  Important 49.4
  Not important 3.8
Average estimated % of patients eligible for Medicaid 33.4
Average estimated % of patients by race or ethnicity†
  Non-Hispanic white 54.9
  Non-Hispanic African American 15.2
  Hispanic 17.8
  Asian or Pacific Islander 5.3
  Native American 1.3
  Multiracial 2.6
  Other 1.0
*
Sample size reduced owing to missing values.
†
Numbers might not add to 100% because of rounding.
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Table 2
Attitudes and Practices of U.S. Obstetrician–Gynecologists Regarding Influenza Vaccination of Pregnant 






Offering influenza vaccination to pregnant patients
  Routinely offered 77.6 85.6 <.001
  Not offered, but referred 21.1 13.3 <.001
  Neither offered or referred 1.1 1.2 .98
Offering influenza vaccination to specific groups of pregnant patients
  Healthy low-risk pregnant patients 75.3 83.4 <.001
  High-risk pregnant patients with underlying chronic conditions 75.3 82.4 <.001
  Pregnant patients with prepregnancy obesity 71.0 77.5 <.01
Recommending influenza vaccination to pregnant patients
  Do not recommend 0.5 0.5 .92
  Recommend during any trimester 88.9 89.9 .85
  Recommend during second or third trimester only 10.6 9.6 .97
Requirements for medical staff to receive influenza vaccination
  Required 33.8 33.9 .99
  Strongly encouraged (but not required) 63.2 62.4 .95
  Not required (and not strongly encouraged) 2.9 3.3 .92
Received influenza vaccination themselves
  Yes 91.7 89.8 .23
  No 8.3 10.2 .29
Data are % unless otherwise specified.
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Table 3
Predictors of Routinely Offering 2009 H1N1 Influenza Vaccine to Pregnant Women by U.S. Obstetrician–






All 858 85.6 -
Practice type‡
  Group obstetrics-gynecology 410 86.6 1.0 (Ref)
  Solo 142 66.9 0.8 (0.7–0.9)
  Multispecialty group 107 98.1 1.1 (1.1–1.2)
  University full-time faculty and practice 98 91.8 1.1 (0.99–1.1)
  Other 100 88.0 1.0 (0.9–1.1)
Considers primary care, preventive medicine an important part of practice§
  Very important 389 88.4 1.2 (1.01–1.4)
  Important 422 84.6 1.1 (0.96–1.4)
  Not important 41 73.2 1.0 (Ref)
Observed serious conditions attributed to influenza-like illness among pregnant 
women‖¶
  Yes (at least one) 269 91.1 1.1 (1.02–1.1)
  No 588 83.0 1.0 (Ref)
Received the 2009 H1N1 influenza vaccination themselves‖
  Yes 768 87.2 1.2 (1.1–1.4)
  No 79 69.6 1.0 (Ref)
CI, confidence interval; Ref, reference.
*
Sample size reduced because of missing values.
†
Routinely offered 2009 H1N1 influenza vaccine to pregnant patients compared with not offered but referred or neither offered or referred.
‡
Adjusted estimates derived from model that included the following variables: practice type and sex.
§
Adjusted estimates derived from model that included the following variables: considers primary care or preventive medicine an important part of 
practice, age, and sex.
‖
Adjusted estimates derived from model that included the following variables: observed serious conditions attributed to influenza-like illness 
among pregnant women, received 2009 H1N1 influenza vaccination themselves, age, and sex.
¶
Conditions include maternal death, pneumonia requiring intensive care, spontaneous abortion or stillbirth, or preterm birth.
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